These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19861161)

  • 1. c-Cbl acts as a mediator of Src-induced activation of the PI3K-Akt signal transduction pathway during TRAIL treatment.
    Song JJ; Kim JH; Sun BK; Alcala MA; Bartlett DL; Lee YJ
    Cell Signal; 2010 Mar; 22(3):377-85. PubMed ID: 19861161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAIL/MEKK4/p38/HSP27/Akt survival network is biphasically modulated by the Src/CIN85/c-Cbl complex.
    Kim J; Kang D; Sun BK; Kim JH; Song JJ
    Cell Signal; 2013 Jan; 25(1):372-9. PubMed ID: 23085457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Cbl-mediated degradation of TRAIL receptors is responsible for the development of the early phase of TRAIL resistance.
    Song JJ; Szczepanski MJ; Kim SY; Kim JH; An JY; Kwon YT; Alcala MA; Bartlett DL; Lee YJ
    Cell Signal; 2010 Mar; 22(3):553-63. PubMed ID: 19932172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAIL-induced caspase/p38 activation is responsible for the increased catalytic and invasive activities of Akt.
    Sun BK; Kim JH; Nguyen HN; Kim SY; Oh S; Lee YJ; Song JJ
    Int J Oncol; 2011 Jan; 38(1):249-56. PubMed ID: 21109947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Src is required for tropomyosin receptor kinase C (TrkC)-induced activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway.
    Jin W; Yun C; Jeong J; Park Y; Lee HD; Kim SJ
    J Biol Chem; 2008 Jan; 283(3):1391-1400. PubMed ID: 17991742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-alpha induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-kappaB/p300 binding in human tracheal smooth muscle cells.
    Lee CW; Lin CC; Lin WN; Liang KC; Luo SF; Wu CB; Wang SW; Yang CM
    Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L799-812. PubMed ID: 17158602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway.
    Li SS; Yang S; Wang S; Yang XM; Tang QL; Wang SH
    Oncol Rep; 2011 Dec; 26(6):1573-9. PubMed ID: 21850380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor.
    Kassenbrock CK; Hunter S; Garl P; Johnson GL; Anderson SM
    J Biol Chem; 2002 Jul; 277(28):24967-75. PubMed ID: 11994282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL).
    Rychahou PG; Murillo CA; Evers BM
    Surgery; 2005 Aug; 138(2):391-7. PubMed ID: 16153452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cbl family of ubiquitin ligases in gastric cancer exosome-induced apoptosis of Jurkat T cells.
    Qu JL; Qu XJ; Qu JL; Qu XJ; Zhao MF; Teng YE; Zhang Y; Hou KZ; Jiang YH; Yang XH; Liu YP
    Acta Oncol; 2009; 48(8):1173-80. PubMed ID: 19863226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cbl negatively regulates erythropoietin-induced growth and survival signaling through the proteasomal degradation of Src kinase.
    Shintani T; Ohara-Waki F; Kitanaka A; Tanaka T; Kubota Y
    Blood Cells Mol Dis; 2014 Dec; 53(4):211-8. PubMed ID: 25084697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSP27 phosphorylation modulates TRAIL-induced activation of Src-Akt/ERK signaling through interaction with β-arrestin2.
    Qi S; Xin Y; Qi Z; Xu Y; Diao Y; Lan L; Luo L; Yin Z
    Cell Signal; 2014 Mar; 26(3):594-602. PubMed ID: 24308965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin ligase c-Cbl is involved in tamoxifen-induced apoptosis of MCF-7 cells by downregulating the survival signals.
    Yan SC; Liu YP; Zhang LY; Qu JL; Xu L; Liu J; Zhang Y; Hou KZ; Teng YE; Qu XJ
    Acta Oncol; 2011 Jun; 50(5):693-9. PubMed ID: 21175263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E3 Ubiquitin Ligase c-Cbl Inhibits Microglia-Mediated CNS Inflammation by Regulating PI3K/Akt/NF-κB Pathway.
    Dong L; Li YZ; An HT; Wang YL; Chen SH; Qian YJ; Wang K; Zhen JL; Fan Z; Gong XL; Zheng Y; Wang XM
    CNS Neurosci Ther; 2016 Aug; 22(8):661-9. PubMed ID: 27156691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of FoxO-dependent c-FLIP expression mediates TRAIL-induced apoptosis in activated hepatic stellate cells.
    Park SJ; Sohn HY; Yoon J; Park SI
    Cell Signal; 2009 Oct; 21(10):1495-503. PubMed ID: 19470406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile myelomonocytic leukaemia-associated mutation in Cbl promotes resistance to apoptosis via the Lyn-PI3K/AKT pathway.
    Bunda S; Qin K; Kommaraju K; Heir P; Ohh M
    Oncogene; 2015 Feb; 34(6):789-97. PubMed ID: 24469048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential response of neuroblastoma cells to TRAIL is independent of PI3K/AKT.
    Efron PA; Chen MK; Iyengar M; Dai W; Nagaram A; Beierle EA
    J Pediatr Surg; 2006 Jun; 41(6):1072-80. PubMed ID: 16769337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human B lymphoma cell surface triggers Cbl tyrosine phosphorylation, its association with p85 subunit, Crk-L and Syk and its dissociation with Vav.
    Lottin-Divoux S; Jean D; Le Romancer M; Frade R
    Cell Signal; 2006 Aug; 18(8):1219-25. PubMed ID: 16289966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DR5-Cbl-b/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells.
    Xu L; Zhang Y; Qu X; Che X; Guo T; Li C; Ma R; Fan Y; Ma Y; Hou K; Li D; Hu X; Liu B; Yu R; Yan H; Gong J; Liu Y
    Mol Oncol; 2017 Dec; 11(12):1733-1751. PubMed ID: 28972304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway.
    Chen KF; Yeh PY; Hsu C; Hsu CH; Lu YS; Hsieh HP; Chen PJ; Cheng AL
    J Biol Chem; 2009 Apr; 284(17):11121-33. PubMed ID: 19261616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.